news

February 6, 2021

Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced financial results for the fourth quarter and full year 2020 and provided a business update. “In 2020,... Read More
February 4, 2021

Thermo Fisher Scientific and JW Therapeutics Announce CAR-T Partnership in China

Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exclusive... Read More
February 4, 2021

Merck KGaA, Darmstadt, Germany, Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare

Merck KGaA, Darmstadt, Germany, which operates its Healthcare business sector as EMD Serono in the US and Canada, today announced that Rehan Verjee has... Read More
February 4, 2021

Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year... Read More
February 4, 2021

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces a collaboration with Gabriel Precision... Read More
February 4, 2021

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group,... Read More
January 19, 2021

Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa... Read More
January 12, 2021

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

Delfi Diagnostics, Inc., a pioneering developer of a new class of high performance, affordable liquid biopsy tests for early cancer detection, has raised $100... Read More
November 17, 2020

Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)

Seven leading diagnostics companies and laboratory service providers have formed the Access to Comprehensive Genomic Profiling Coalition (ACGP). The goal of the organization is... Read More
November 12, 2020

Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative... Read More
November 12, 2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the completion... Read More
November 12, 2020

LUNGevity Foundation Launches Inhale for Life: Right Track Public Service and Social Media Campaign During Lung Cancer Awareness Month

Kicking off Lung Cancer Awareness Month, LUNGevity, the nation’s leading lung cancer-focused nonprofit organization, launched its Inhale for Life: Right Track public service campaign.... Read More
November 12, 2020

Caris Life Sciences Announces Huntsman Cancer Institute Joins its Precision Oncology Alliance

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Huntsman Cancer Institute (HCI)... Read More
October 27, 2020

Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening

Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. (“Thrive”), a healthcare company dedicated to incorporating earlier cancer detection into routine medical care,... Read More
October 1, 2020

19 Organizations from the Healthcare Community Unite to Form COVID-19 Testing Industry Consortium

Widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect needed to limit the spread of the disease. By creating... Read More
October 1, 2020

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

Sema4, a patient-centered health intelligence company, today announced that it has entered into a research agreement with Janssen Research & Development, LLC (Janssen) to... Read More
October 1, 2020

Ionis and Genuity Science announce agreement designed to rapidly translate genomic insights into therapeutics

Genuity Science, a genomics and data insights organization and Ionis Pharmaceuticals (NASDAQ: IONS), the leader in antisense therapeutics, today announced a broad, multi-year collaboration... Read More
October 1, 2020

Cancer Genomic Screening Program LC-SCRUM-Asia Adopts Latest Thermo Fisher Scientific NGS Solutions

LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific’s Ion Torrent Genexus System* and Oncomine Precision Assay*, a pan-cancer panel, to... Read More
September 10, 2020

Bristol Myers Squibb Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers with High Unmet Medical Need

Bristol Myers Squibb (NYSE:BMY) today announced the presentation of research spanning 15 different cancers at the upcoming European Society for Medical Oncology (ESMO) Virtual... Read More
September 10, 2020

AstraZeneca aims to transform cancer treatment and advance clinical practice with data presented at ESMO 2020

AstraZeneca will present new developments in pursuit of its ambition to eliminate cancer as a cause of death at the European Society for Medical... Read More
September 10, 2020

Natera Launches Proposed Follow-On Offering

Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of $250,000,000 of... Read More
September 10, 2020

Lilly Oncology to Showcase New Data from Robust Cancer Research Pipeline at ESMO Virtual Congress 2020

Data from 20 studies across Eli Lilly and Company’s (NYSE: LLY) oncology product portfolio will be presented at the European Society for Medical Oncology... Read More
September 10, 2020

FDA Approves First NGS-Based Companion Diagnostic for RET Fusion-Positive Non-Small Cell Lung Cancer

The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx)... Read More
September 3, 2020

Blueprint Medicines Strengthens Leadership with Appointment of Fouad Namouni, M.D., as President, Research & Development

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced the appointment of... Read More
September 3, 2020

U.S. Food and Drug Administration Approves Onureg® (azacitidine tablets), a New Oral Therapy, as Continued Treatment for Adults in First Remission with Acute Myeloid Leukemia

Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Onureg® (azacitidine 300 mg tablets, CC-486) for... Read More
1 2 3 22